- KR₩1tn
- KR₩1tn
- KR₩695bn
- 72
- 46
- 57
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.38 | ||
| Price to Tang. Book | 1.32 | ||
| Price to Free Cashflow | 14.51 | ||
| Price to Sales | 1.58 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -5.08% | ||
| Return on Equity | -3.42% | ||
| Operating Margin | -27.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 1,686,163.03 | 2,929,960.84 | 2,932,001.44 | 655,676.51 | 694,573.8 | 817,900 | 915,900 | 56.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +19217 | +87.54 | -18.92 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SD Biosensor Inc is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 27th, 2010
- Public Since
- July 16th, 2021
- No. of Shareholders
- 114,033
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Korea Exchange - KSE- Shares in Issue
- 117,888,892
- Address
- 4-5F, C Dong, Digital Empire, SUWON, 16690
- Web
- http://sdbiosensor.co.kr/
- Phone
- +82 313000400
- Auditors
- KPMG Samjong Accounting Corp
Upcoming Events for 137310
Similar to 137310
Bionote
Korea Exchange - KSE
Dentium Co
Korea Exchange - KSE
Hancom Lifecare
Korea Exchange - KSE
Shinhung Co
Korea Exchange - KSE
FAQ
As of Today at 23:07 UTC, shares in SD Biosensor are trading at KR₩9,310. This share price information is delayed by 15 minutes.
Shares in SD Biosensor last closed at KR₩9,310 and the price had moved by -7.09% over the past 365 days. In terms of relative price strength the SD Biosensor share price has underperformed the FTSE Developed Asia Pacific Index by -6.03% over the past year.
The overall consensus recommendation for SD Biosensor is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe SD Biosensor dividend yield is 2.15% based on the trailing twelve month period.
Last year, SD Biosensor paid a total dividend of KR₩200, and it currently has a trailing dividend yield of 2.15%. We do not have any data on when SD Biosensor is to next pay dividends.
We do not have data on when SD Biosensor is to next pay dividends. The historic dividend yield on SD Biosensor shares is currently 2.15%.
To buy shares in SD Biosensor you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩9,310, shares in SD Biosensor had a market capitalisation of KR₩1tn.
Here are the trading details for SD Biosensor:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 137310
Based on an overall assessment of its quality, value and momentum SD Biosensor is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in SD Biosensor is KR₩11,071. That is 18.92% above the last closing price of KR₩9,310.
Analysts covering SD Biosensor currently have a consensus Earnings Per Share (EPS) forecast of -KR₩668 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SD Biosensor. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +12.11%.
As of the last closing price of KR₩9,310, shares in SD Biosensor were trading -8.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SD Biosensor PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩9,310.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SD Biosensor's management team is headed by:
- Tae Young Heo - PRE
- Hyo Keun Lee - CCE